Our Latest Stories

Our Science
March 26, 2025
Fast-Tracking Hope: How Our Translational Medicine Team is Changing the Drug Development Game

United by Purpose
Each of us plays a unique role in bringing our purpose to life.
About Us

Who We Are
We are an innovative global healthcare company.
Our Pipeline
5
Therapeutic areas
83
Compounds in clinical development
26
Clinical trials in phase 3

Pursue Progress. Discover Extraordinary.
Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.
Our Latest Press Releases
March 28, 2025
Press Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors
March 28, 2025
Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD
March 26, 2025
Press Release: Chlamydia vaccine candidate granted fast track designation by the US FDA
March 25, 2025
Press Release: Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis